![Jeffrey L. Cummings pictured in a white lab coat in his lab on UNLV's campus](/sites/default/files/styles/768_width/public/releases/main-images/D72855_001.jpg?itok=9WPHzqnf)
Study Finds Nonprofits, Federal Government Surpass Pharma to Lead Alzheimer's Drug Development
UNLV research professor Jeffrey L. Cummings examines Alzheimer's clinical trials pipeline in two new studies.
UNLV research professor Jeffrey L. Cummings examines Alzheimer's clinical trials pipeline in two new studies.
Dr. Jeffrey Cummings and multidisciplinary research team to expand UNLV’s clinical trials observatory with $3 million grant.
A yearlong collection of UNLV faculty making the news for their discoveries and contributions to the community.
As summer heats up, so do the accomplishments on UNLV’s campus.
Dr. Jeffrey Cummings examines drug pipeline for treatments, and finds reason for optimism.
A collection of news stories featuring the people and programs of UNLV.
The Chambers-Grundy Center for Transformative Neuroscience will advance research and the science of treatment for Alzheimer’s and other neurological disorders.
A collection of stories highlighting UNLV faculty and students who made the news in 2019.